GlassScriptPhysician profile
Charles J Gbur
NPI 1184626483
$36,073.00
in general payments reported to CMS, 2019-2025
46 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,257 · 2020: $741 · 2021: $2,256 · 2022: $5,726 · 2023: $5,862 · 2024: $5,220 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,160 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,113 · Food and Beverage: $6,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,159.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,112.50 |
| Food and Beverage | $6,821.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,680.06 | 2021-2025 | Symplicity G3, Turbohawk, In.Pact Admiral |
| Abbott Laboratories | $6,337.47 | 2019-2025 | Aveir, Acculink, Perclose Proglide |
| Inari Medical, INC. | $5,292.62 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $2,659.24 | 2021-2023 | Indigo System |
| Cardiovascular Systems INC. | $1,203.90 | 2019-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $971.84 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $654.86 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Novartis Pharmaceuticals Corporation | $632.03 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $501.19 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.51 | 2019-2025 | Jardiance |
| Ekos Corporation | $381.40 | 2019 | |
| Abiomed | $370.91 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $357.90 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $322.02 | 2019-2025 | Lifevest |
| Amgen INC. | $314.51 | 2019-2025 | Repatha, Repatha |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $265.88 | 2022-2025 | Verquvo |
| Stryker Corporation | $214.16 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Pfizer INC. | $167.85 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $151.69 | 2019-2020 | |
| Biotronik INC. | $121.59 | 2019 | |
| Novo Nordisk INC | $101.18 | 2024-2025 | Wegovy |
| Medtronic Vascular, INC. | $99.11 | 2020 | |
| Amarin Pharma, INC. | $83.38 | 2019-2021 | |
| Bardy Diagnostics, INC. | $80.00 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $77.49 | 2022-2023 | Opsumit, Uptravi |
| Philips North America LLC | $68.60 | 2019-2025 | Ecc Solutions |
| Chiesi USA, INC. | $66.51 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $60.33 | 2022 | |
| Astellas Pharma US INC | $47.84 | 2019-2021 | |
| Heartflow, INC. | $44.15 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $41.26 | 2024 | Arcalyst |
| Anumana, INC. | $35.15 | 2025 | Ecg-Ai Lef |
| Convatec INC. | $32.88 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $31.11 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.40 | 2022-2025 | |
| Abbvie INC. | $24.72 | 2024 | |
| United Therapeutics Corporation | $20.74 | 2025 | Tyvaso |
| Organogenesis INC. | $19.59 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $19.22 | 2023 | Inpefa |
| Edwards Lifesciences Corporation | $18.98 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Terumo Medical Corporation | $16.49 | 2021 | |
| Cordis US Corp. | $15.79 | 2023 | Rain Sheath Transradial |
| Takeda Pharmaceuticals U.S.A., INC. | $15.13 | 2022 | |
| Cardiva Medical, INC. | $14.33 | 2022 | |
| Scpharmaceuticals INC. | $13.50 | 2025 | |
| Lundbeck LLC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gbur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.